U.S. Venture Partners related stories
All articles and analysis
HealthJoy inks $30m Series CChicago-based HealthJoy, a benefits experience platform, has secured $30 million in Series C funding, according to a blog post.
U.S. Venture Partners holds final closing of twelfth fundThe California firm raised $340 million for its latest vehicle.
- USVP racks up $340 mln for 12th fund
U.S. Venture Partners has closed its twelfth fund at $340 million.
- Epsagon locks in $16 mln Series A
Epsagon, a microservices application monitoring company, has secured $16 million in Series A funding.
Where are they now? Social CapitalWe followed up with some of Social Capital's former partners to find out what came of the executives who left the firm.
ShiraTronics nabs $33 mln Series ABrooklyn Park, Minnesota-based ShiraTronics Inc, a private medical device company, has raised $33 million in Series A financing. USVP, Amzak Health and Strategic HealthCare Investment Partners led the round with participation from other investors that included Aperture Ventures and LivaNova PLC.
Toncheva promoted at USVP, Investor bails on Vision Fund, and a monthly recap of other VCs on the MoveA compilation of personnel moves from the previous four weeks at various firms, including USVP, Next Ventures and SoftBank
- U.S. Venture Partners elevates Toncheva
U.S. Venture Partners said Oct. 9 that it promoted Dafina Toncheva to general partner.
- Kenna Security raises $48 mln
Kenna Security said Sept. 30 that it raised $48 million in a Series D round of funding. New investors include Sorenson Capital and Citi Ventures. Kenna’s existing investors, including Bessemer Venture Partners, U.S. Venture Partners, Costanoa Ventures, Hyde Park Angels, and OurCrowd, joined the funding round. Kenna provides risk-based vulnerability management services.
- Edgewise Therapeutics locks in $50 mln Series B
Boulder, Colorado-based Edgewise Therapeutics, a preclinical company developing small molecule therapies for musculoskeletal diseases, has secured $50 million in Series B financing. Novo Holdings A/S and U.S. Venture Partners led the round.